Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Trends in Cardiovascular Medicine Année : 2020

Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome

Résumé

Dual antiplatelet therapy (DAPT), with aspirin plus a P2Y12 inhibitor agent, is the cornerstone treatment after percutaneous coronary intervention for acute coronary syndrome. Based on randomized clinical trial using aspirin and clopidogrel, a DAPT duration of 12 months has been recommended after an acute coronary syndrome. Despite the development of more potent antiplatelet agents (i.e. prasugrel and ticagrelor) and the reduction in ischemic recurrences after acute coronary syndrome, 12 months DAPT currently remains the gold standard. However, a significant proportion of patients experience recurrent ischemic events beyond the first 12 months after an acute coronary syndrome. Meanwhile, with more effective antiplatelet agent, bleeding has become a major safety concern on DAPT. Therefore, the ischemic and bleeding risk balance is central considering the duration of DAPT after an acute coronary syndrome. This review aims to report the evidence for an optimization and individualization of DAPT duration after an acute coronary syndrome.
Fichier principal
Vignette du fichier
1-s2.0-S1050173819300738-main.pdf (745.24 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03149583 , version 1 (23-02-2021)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Pierre Deharo, Thomas Cuisset. Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome. Trends in Cardiovascular Medicine, 2020, 30 (4), pp.198-202. ⟨10.1016/j.tcm.2019.05.008⟩. ⟨hal-03149583⟩
124 Consultations
191 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More